Skip to main navigation Skip to search Skip to main content

Galactosemia as a cause of neonatal ascitis and cholestasis

Marina Álvarez Beltrán, Marina Álvarez, Sonia Cañadas, Oscar Segarra, Ramón Tormo, Jordi Roqueta

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Introduction. Galactosemia is a metabolic disease with systemic manifestations secondary to the inability to metabolize galactose, resulting in accumulation of galactose-1-phosphate in liver, kidneys and brain. Case Report. We describe the case of a 32-day old infant who presented with cholestatic jaundice, abdominal distension and deficits in hepatic synthetic function. Abdominal ultrasound showed tension ascitis without an obvious extra-hepatic cause. A metabolic work-up was performed, and alpha-1-antitrypsine, tyrosinemia, and cystic fibrosis were ruled out. The presence of reducing substances in the urine suggested the diagnosis of galactosemia. Increased concentration of galactose-1-phosphate, and deficit of galactose-1-phosphate uridyl transferase were found in red blood cells, thus confirming the diagnosis. Elimination of galactose from the diet reversed the liver da-mage and the patient recovered completely. Comments. The unique feature of this case was the presentation with tension ascitis in the absence of the more characteristic symptoms of the disease. The early elimination of galactose from the diet prevented further progression.
Original languageEnglish
Pages (from-to)235-240
JournalPediatria Catalana
Volume67
Issue number5
Publication statusPublished - 1 Sept 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Ascitis
  • Cholestasis
  • Galactosemia
  • Metabolic disease

Fingerprint

Dive into the research topics of 'Galactosemia as a cause of neonatal ascitis and cholestasis'. Together they form a unique fingerprint.

Cite this